Neurophysiological profile of peripheral neuropathy associated with childhood mitochondrial disease.

[1]  G. Plant,et al.  Peripheral neuropathy predicts nuclear gene defect in patients with mitochondrial ophthalmoplegia , 2014, Brain : a journal of neurology.

[2]  Z. Sheng,et al.  Mitochondrial trafficking and anchoring in neurons: New insight and implications , 2014, The Journal of cell biology.

[3]  M. Zeviani,et al.  SURF1 deficiency causes demyelinating Charcot-Marie-Tooth disease , 2013, Neurology.

[4]  Robert W. Taylor,et al.  SURF1 deficiency: a multi-centre natural history study , 2013, Orphanet Journal of Rare Diseases.

[5]  Robert W. Taylor,et al.  What is influencing the phenotype of the common homozygous polymerase-γ mutation p.Ala467Thr? , 2012, Brain : a journal of neurology.

[6]  Jacqueline A Palace,et al.  Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease , 2012, Neurology.

[7]  M. Menezes,et al.  Peripheral neuropathy associated with mitochondrial disease in children , 2012, Developmental medicine and child neurology.

[8]  T. Matsuishi,et al.  Beneficial effect of pyruvate therapy on Leigh syndrome due to a novel mutation in PDH E1α gene , 2012, Brain and Development.

[9]  Qian Cai,et al.  Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration , 2012, Nature Reviews Neuroscience.

[10]  M. Hirano,et al.  Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy. , 2011, Brain : a journal of neurology.

[11]  M. Kiernan,et al.  Acute, Reversible Axonal Energy Failure During Stroke-Like Episodes in MELAS , 2010, Pediatrics.

[12]  J. Milbrandt,et al.  Mitofusin 2 Is Necessary for Transport of Axonal Mitochondria and Interacts with the Miro/Milton Complex , 2010, The Journal of Neuroscience.

[13]  J. Pollard,et al.  European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First Revision , 2010, European journal of neurology.

[14]  L. Schöls,et al.  ATAXIA WITH OPHTHALMOPLEGIA OR SENSORY NEUROPATHY IS FREQUENTLY CAUSED BY POLG MUTATIONS , 2009, Neurology.

[15]  J. McCaffery,et al.  Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion. , 2009, Molecular biology of the cell.

[16]  A. Paetau,et al.  Recessive twinkle mutations cause severe epileptic encephalopathy. , 2009, Brain : a journal of neurology.

[17]  D. Bonneau,et al.  Mitochondrial complex I deficiency in GDAP1-related autosomal dominant Charcot-Marie-Tooth disease (CMT2K) , 2009, neurogenetics.

[18]  J. Pollard,et al.  Histopathological Findings in Hereditary Motor and Sensory Neuropathy of Axonal Type With Onset in Early Childhood Associated With Mitofusin 2 Mutations , 2008, Journal of neuropathology and experimental neurology.

[19]  J. Ganesh,et al.  Molecular and clinical genetics of mitochondrial diseases due to POLG mutations , 2008, Human mutation.

[20]  Yi-Chung Lee,et al.  [Charcot-Marie-Tooth disease]. , 2008, Acta neurologica Taiwanica.

[21]  Y. Crow,et al.  Variable Phenotype Including Leigh Syndrome with a 9185T>C Mutation in the MTATP6 Gene , 2007, Neuropediatrics.

[22]  M. Zeviani,et al.  The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. , 2006, Brain : a journal of neurology.

[23]  D. Theriaque,et al.  Therapeutic potential of dichloroacetate for pyruvate dehydrogenase complex deficiency. , 2006, Mitochondrion.

[24]  S. Dimauro,et al.  Nerve conduction abnormalities in patients with MELAS and the A3243G mutation. , 2006, Archives of neurology.

[25]  J. Pollard,et al.  European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society , 2006, European journal of neurology.

[26]  G. Mitchell,et al.  Intermittent peripheral weakness as the presenting feature of pyruvate dehydrogenase deficiency , 2006, European Journal of Pediatrics.

[27]  S. Dimauro,et al.  Dichloroacetate causes toxic neuropathy in MELAS , 2006, Neurology.

[28]  P. Hollenbeck,et al.  The axonal transport of mitochondria , 2005, Journal of Cell Science.

[29]  Axel Niemann,et al.  Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network , 2005, The Journal of cell biology.

[30]  A. Paetau,et al.  Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. , 2005, American journal of human genetics.

[31]  M. Zeviani,et al.  Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA. , 2005, Brain : a journal of neurology.

[32]  M. Pericak-Vance,et al.  Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A , 2004, Nature Genetics.

[33]  M. Hirano,et al.  Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE): A Disease of Two Genomes , 2004, The neurologist.

[34]  P. Carney,et al.  Juvenile-Onset Leigh Syndrome With an Acute Polyneuropathy at Presentation , 2003, Journal of child neurology.

[35]  Erik E. Griffin,et al.  Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development , 2003, The Journal of cell biology.

[36]  A. Green,et al.  Familial childhood onset neuropathy and cirrhosis with the 4977bp mitochondrial DNA deletion. , 2002, American journal of medical genetics.

[37]  S. Hinderer,et al.  Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. , 2000, Brain : a journal of neurology.

[38]  R. Artuch,et al.  [Aspects of neuropathy in mitochondrial diseases]. , 2000, Revista de neurologia.

[39]  E. Naito,et al.  Outcome of thiamine treatment in a child with Leigh disease due to thiamine-responsive pyruvate dehydrogenase deficiency. , 2000, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[40]  S. Scherer,et al.  Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy. , 2000, Brain : a journal of neurology.

[41]  S. Scherer.  Axonal pathology in demyelinating diseases , 1999, Annals of neurology.

[42]  S. Seneca,et al.  Biochemical and genetic studies of four patients with pyruvate dehydrogenase E1α deficiency , 1997, Human Genetics.

[43]  J Zhang,et al.  Study of Nerve Conduction and Late Responses in Normal Chinese Infants, Children, and Adults , 1997, Journal of child neurology.

[44]  J. Christodoulou,et al.  Leigh syndrome: Clinical features and biochemical and DNA abnormalities , 1996, Annals of neurology.

[45]  T. Ozawa,et al.  Acute peripheral neuropathy, rhabdomyolysis, and severe lactic acidosis associated with 3243 A to G mitochondrial DNA mutation. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[46]  A. Munnich,et al.  Leigh Syndrome: Pyruvate Dehydrogenase Defect. A Case With Peripheral Neuropathy , 1994, Journal of child neurology.

[47]  G. Ponsot,et al.  El Pyruvate Dehydrogenase Deficiency in a Child with Motor Neuropathy , 1993, Pediatric Research.

[48]  S. Seneca,et al.  Biochemical and genetic studies of four patients with pyruvate dehydrogenase E1 alpha deficiency. , 1997, Human genetics.

[49]  S. Coker.  Leigh disease presenting as Guillain-Barré syndrome. , 1993, Pediatric neurology.

[50]  D. Samuelson,et al.  Chronic toxicity of dichloroacetate: possible relation to thiamine deficiency in rats. , 1990, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[51]  G. Guazzi,et al.  Congenital lactic acidosis due to a defect of pyruvate dehydrogenase complex (E1). Clinical, biochemical, nerve biopsy study and effect of therapy. , 1990, European neurology.